SCHEMBL30801735

SCHEMBL30801735

COc1ccc(C(C)CN2CCN3CCNC[C@@H]3C2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.37
▸ HTR2C P28335 3/20 0.37
▸ HTR2B P41595 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CHRM2 P08172 2/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ ABCB1 P08183 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801858 0.87 SLC6A2 (0.40) HTR2AHTR2CHTR2BALDH1A1SLC6A2
SCHEMBL30801854 0.86 ZDHHC9 (0.38) —
SCHEMBL30801878 0.86 TAAR1 (0.39) HTR2AHTR2CHTR2BALDH1A1
SCHEMBL30801792 0.84 HSD11B1 (0.36) HTR2AHTR2CHTR2BOPRD1HSD11B1
SCHEMBL30801824 0.82 HSD11B1 (0.34) HTR2AHTR2CHTR2BHSD11B1
SCHEMBL23574138 0.78 LMNA (0.38) ALDH1A1LMNATSHRCHRM2CHRM1
SCHEMBL30801804 0.78 HTR2C (0.42) HTR2AHTR2CHTR2BSLC6A2
SCHEMBL30801806 0.77 HTR2A (0.35) HTR2AHTR2CHTR2B
SCHEMBL30801876 0.77 DRD2 (0.38) HTR2AHTR2CHTR2BSLC6A2
SCHEMBL30801898 0.76 HTR2C (0.37) HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 — — EP claimed
Send feedback